EichorEICHOR
Condition: Solid Neoplasms Synced from ClinicalTrials.gov · August 08, 2026

Recruiting studies: Solid Neoplasms

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors
Phase N/A · 1 location(s) · Wake Forest University Health Sciences · NCT00900471ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (
Phase 1 · 9 location(s) · Acepodia Biotech, Inc. · NCT06415487HEAT Trial (HER2 Antibody Therapy With Lutetium-177)
EARLY_Phase 1 · 5 location(s) · Radiopharm Theranostics, Ltd · NCT06824155A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
Phase 1 · 8 location(s) · Erasca, Inc. · NCT06983743Futibatinib in Combination With (Chemo)Immunotherapy in Colorectal Cancer and Other Solid Tumor Entities
Phase 2 · 10 location(s) · Institut für Klinische Krebsforschung IKF GmbH at Krankenhau · NCT06722183Intratumor CpG-ODN Injection Boosters Immune Killing Against in Situ Tumor Antigen Release for Advanced Solid Tumors
Phase 1 · 1 location(s) · Second Affiliated Hospital of Guangzhou Medical University · NCT04952272Precision Medicine for Every Child With Cancer
Phase N/A · 11 location(s) · Australian & New Zealand Children's Haematology/Oncology Gro · NCT05504772Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases
Phase N/A · 1 location(s) · University Hospital, Toulouse · NCT05318196Study of JYP0015 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Phase 2 · 1 location(s) · Guangzhou JOYO Pharma Co., Ltd · NCT06895031Phase III Clinical Study of VC004 in Patients With Localized Advanced/ Metastatic Solid Tumors
Phase 3 · 1 location(s) · Jiangsu vcare pharmaceutical technology co., LTD · NCT06658353Ambient Sensing Room to Detect Early Signs of Adverse Events in Hospitalized Patients With Cancer
Phase N/A · 1 location(s) · Mayo Clinic · NCT07477886Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor
Phase 1/Phase 2 · 9 location(s) · Sichuan Enray Pharmaceutical Sciences Company · NCT07433283Safety, Tolerability, and Preliminary Antitumor Activity of Cationic Peptide-IL22BP mRNA in Advanced Solid Tumors
Phase 1 · 1 location(s) · West China Hospital · NCT07583654A First-in-Human Escalation and Expansion Study of Patients With Advanced Solid Tumors
Phase 1 · 2 location(s) · JiaRay Group · NCT06783569A Study of ASKG915 in Patients With Selected Advanced Solid Tumors.
Phase 1/Phase 2 · 4 location(s) · AskGene Pharma, Inc. · NCT05867420Sapu003 in Advanced mTOR-sensitive Solid Tumors
Phase 1 · 1 location(s) · SAPU NANO (US) LLC · NCT07369505AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
Phase 1 · 3 location(s) · Avacta Life Sciences Ltd · NCT07454642Topical Tretinoin Prophylaxis for Anti-EGFR Induced Skin Toxicity in Patients With Solid Tumors
Phase 2 · 1 location(s) · University of Utah · NCT06358677Study of XB010 in Subjects With Solid Tumors
Phase 1 · 20 location(s) · Exelixis · NCT06545331A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
Phase 1/Phase 2 · 13 location(s) · IDEAYA Biosciences · NCT07174583A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerabili
Phase 1/Phase 2 · 10 location(s) · Lumara Bio Oncologics GmbH · NCT05706129Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
Phase N/A · 8 location(s) · AIDS Malignancy Consortium · NCT05663502Exploratory Study of Super DC Cell Injection in Preventing Recurrence After Radical Surgery for Tumors
Phase 1/Phase 2 · 1 location(s) · Shanghai Cell Therapy Group Co.,Ltd · NCT07146672Safety and Tolerability Study of 68Ga/177Lu-BRP-020063 in Advanced Solid Tumors
EARLY_Phase 1 · 1 location(s) · Shanghai General Hospital, Shanghai Jiao Tong University Sch · NCT07439120Optimizing and Personalising Azacitidine Combination Therapy for Treating Solid Tumours QPOP and CURATE.AI
Phase 1/Phase 2 · 1 location(s) · National University Hospital, Singapore · NCT05381038A Study of BL-B16D1 in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumor
Phase 1 · 1 location(s) · Sichuan Baili Pharmaceutical Co., Ltd. · NCT06469008A Trial of SHR-2017 Injection in Patients With Bone Metastases From Solid Tumors
Phase 2 · 1 location(s) · Suzhou Suncadia Biopharmaceuticals Co., Ltd. · NCT07028268An Exploratory Study by Fast CAR T Cells
EARLY_Phase 1 · 1 location(s) · Shanghai Cell Therapy Group Co.,Ltd · NCT06327997Evaluation of the Effect of Cordycepin on CD8+ Lymphocytopenia in Patients With Solid Tumors
Phase 2 · 1 location(s) · Second Affiliated Hospital of Soochow University · NCT07258160A Phase I Study of HRS-7172 in Participants With Advanced Solid Tumors Harboring RAS Mutations or Amplifications
Phase 1 · 1 location(s) · Jiangsu HengRui Medicine Co., Ltd. · NCT07142980
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.